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Abstract
Neural crest cells originate in the dorsal neural tube but subsequently undergo an epithelial-to-mesenchymal transition (EMT), delaminate, and
migrate to diverse locations in the embryo where they contribute to a variety of derivatives. Cadherins are a family of cell–cell adhesion molecules
expressed in a broad range of embryonic tissues, including the neural tube. In particular, cadherin6B (Cad6B) is expressed in the dorsal neural
tube prior to neural crest emigration but is then repressed by the transcription factor Snail2, expressed by premigratory and early migrating cranial
neural crest cells. To examine the role of Cad6B during neural crest EMT, we have perturbed Cad6B protein levels in the cranial neural crest-
forming region and have examined subsequent effects on emigration and migration. The results show that knock-down of Cad6B leads to
premature neural crest cell emigration, whereas Cad6B overexpression disrupts migration. Our data reveal a novel role for Cad6B in controlling
the proper timing of neural crest emigration and delamination from the neural tube of the avian embryo.
© 2007 Elsevier Inc. All rights reserved.Keywords: Neural crest; Cadherin; EMT; Delamination; Cell adhesion; (E)migration; Chick embryoIntroduction
The vertebrate neural crest is a transient embryonic
population of highly migratory cells that arises during
neurulation, migrates extensively, and differentiates to create
numerous distinct structures. In the avian embryo, precursors to
neural crest cells (termed the premigratory neural crest) reside in
the dorsal portion of the neural epithelium, the future central
nervous system. Prior to neural crest migration, these precursors
undergo changes in gene expression and morphology that
facilitate an epithelial-to-mesenchymal transition (EMT) char-
acterized by loss of the adherent, epithelial nature of the
premigratory neural crest and subsequent acquisition of a
mesenchymal, motile phenotype that exemplifies the migratory
neural crest proper (Le Douarin and Kalcheim, 1999; Bare-
mbaum and Bronner-Fraser, 2005; Noden and Trainor, 2005;
Sauka-Spengler and Bronner-Fraser, 2006).⁎ Corresponding author. Fax: +1 626 395 7717.
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doi:10.1016/j.ydbio.2007.09.056EMTs are a hallmark of many distinct developmental
processes, including mesoderm formation during gastrulation
and tumor cell metastasis (Leptin et al., 1992; Ciruna et al., 1997;
Thiery, 2002; Hemavathy et al., 2004). Members of the Snail
family of transcription factors have been identified as having a
central role in EMTs, acting as repressors that down-regulate
expression of genes that help maintain an epithelial, polarized
cell type. The molecular basis of Snail-mediated repression in
various EMT events, both in the developing embryo and during
tumorigenesis, has been well documented (Hemavathy et al.,
2000; Nieto, 2002; Barrallo-Gimeno and Nieto, 2005; De
Craene et al., 2005; Pérez-Mancera et al., 2005). Previous
studies have demonstrated that one of the key molecular events
underlying such EMTs is the down-regulation of the epithelial
cadherin, E-cadherin (E-cad). In vitro and in vivo experiments
have revealed that this repression occurs through a direct
interaction between Snail proteins and Snail binding sites (E
boxes) in a palindromic position in the promoter region of E-cad
(Giroldi et al., 1997; Cano et al., 2000; Bolós et al., 2003; Côme
et al., 2004). Subsequent down-regulation of E-cad expression,
at the transcriptional level by Snail proteins as well as post-
transcriptionally through endocytosis and protein degradation
(Palacios et al., 2005), results in the dismantling of adherens
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order to facilitate cell motility.
We have recently shown that the EMT that characterizes
avian neural crest cell emigration from the dorsal neural tube
involves the direct transcriptional repression of another
Cadherin, cadherin6B (Cad6B), by Snail2. This represents the
first reported direct target of Snail2 in the neural crest (Taneyhill
et al., 2007) and defines a molecular mechanism for the
decrease in Cad6B expression observed during neural crest
EMT and migration (Nakagawa and Takeichi, 1995, 1998).
However, little is known about the function of Cad6B itself
during neural crest EMT/emigration. To address this pertinent
question, we have investigated the consequences of perturbing
Cad6B expression in the dorsal neural tube of the chick embryo
on subsequent neural crest emigration and migration. Our data
reveal a previously unappreciated and critical role for Cad6B in
temporally regulating neural crest emigration.
Materials and methods
Chicken embryo culture
Fertilized chicken eggs were obtained from AA Enterprises (Ramona, CA)
and incubated on their sides at 38 °C in humidified incubators (Lyon Electric
Co., Chula Vista, CA). Embryos were staged according to the number of pairs of
somites (somite stage (ss)).
Design and electroporation of Cad6B antisense morpholino
A 3′ lissamine-labeled antisense Cad6B morpholino (MO), 5′-ACCA-
GAAGCAATGGTAAGTTCTCAT-3′, was designed to target the Cad6B
mRNA according to the manufacturer's criteria (GeneTools, LLC) in order to
prevent translation of Cad6B protein. A standard lissamine-labeled MO
(GeneTools, LLC) was utilized as a control, as well as a 5 base pair mismatch
lissamine-labeled antisense Cad6B MO 5′-ACgAGAAcCAATcGTAAcTTCT-
gAT-3′ (mutated bases are in lower case). MOs were introduced into the
developing chick embryo at the required stage using a modified version of the
electroporation technique (Itasaki et al., 1999). Briefly, the MO was injected at
250 μM into the lumen of the neural tube at the desired axial level and 2, 25 V,
25 ms pulses were applied across the embryo.
Overexpression of Cad6B in vivo
The full-length Cad6B gene was directionally cloned by PCR from a full-
length Cad6B clone (Dr. Stephen Price) into the pCIG chick expression
construct to produce pCIG-Cad6B. The clone was sequenced to confirm
accuracy. The control (pCIG) or pCIG-Cad6B expression construct was
introduced in to the embryo at a concentration of 1.4 μg/μl, as described
previously in Materials and methods for the electroporation of MOs.
Whole-mount in situ hybridization
Whole-mount in situ hybridizations were performed as previously described
(Xu and Wilkinson, 1998; Taneyhill et al., 2007). Stained embryos were imaged
in 70% glycerol using a camera mounted on a Zeiss Stemi SV11 microscope.
Transverse-sections were obtained by cryostat-sectioning gelatin-embedded
embryos at 14 μm. Images were processed using Adobe Photoshop 7.0 (Adobe
Systems).
Chick embryo and explant culture
Operated embryos were removed from the yolk sac using forceps and
scissors, and a microscope was then used to count the number of somites. MO-or pCIG/pCIG-Cad6B-electroporated embryos were re-incubated for 30 minutes
or 4 hours (h), respectively, prior to dissection. Dissection of appropriate tissue
was performed using tungsten needles in PB-1 standard medium or Ringer's
solution. Culturing of neural fold explants was performed by coating tissue
culture dishes with a 1:100 dilution of recombinant fibronectin (BD
Biosciences) and poly-L-lysine (Sigma) in serum-free DMEM+N2 supplement
(GIBCO-BRL) and mouth pipetting neural folds onto the coated dishes.
Explants were cultured for 2.5 h prior to fixation and immunostaining.
Immunohistochemistry
Immunohistochemical detection of Cad6B (DSHB, clone CCD6B-1; 1:100)
was performed as previously described (Nakagawa and Takeichi, 1998), with an
Alexa-Fluor 488 goat anti-mouse IgG secondary antibody (Molecular Probes,
1:500). Immunohistochemical detection of Cadherin7 (DHSB, clone CCD7-1;
1:100) was performed as previously described (Nakagawa and Takeichi, 1998),
with an Alexa-Fluor 488 goat anti-mouse IgG1 secondary antibody (Molecular
Probes, 1:200). Immunohistochemical detection of N-cadherin (DHSB, clone
NCD2; 1:50), phospho-histone H3 (1:500), and HNK-1 (1:100) was performed
using similar methods. Embryos were washed, mounted, imaged, and assessed
for antibody efficacy as well as presence of MO or GFP. Embryos with good
antibody staining and MO or GFP expression were selected and cryostat-
sectioned (14μm). SectionswereDAPI-stained to identify individual nuclei prior
to mounting and imaging. For detection and quantification of apoptosis in
sections, an in situ cell death detection kit (‘TUNEL’ technology) was employed
following themanufacturer's instructions (Roche). Samples were analyzed under
the fluorescence microscope at either 594 nm or 488 nm.
Cell counts of Sox10- or Snail2-expressing cells
Embryos electroporated with control MO or Cad6B MO and hybridized
with Sox10 or Snail2 antisense ribo-probes were imaged and subsequently
cryostat-sectioned at 14 μm. Sections were stained with DAPI to enable the
identification of individual nuclei and mounted for imaging. In midbrain regions
where neural crest cell migration had commenced, 7–10 serial images were
captured for at least 5 embryos that had MO localized to the dorsal neural tube.
Every DAPI positive nuclei that was surrounded by cytoplasmic Sox10 or
Snail2 staining in the migratory streams on both the electroporated and non-
electroporated side was counted and recorded. The fold differences were
averaged over the number of sections in which cells were counted, and the
standard error of the mean was calculated and compared for embryos
electroporated with either control MO or Cad6B MO. Significance of results
was established using the unpaired Student's t test.
Cell counts for in vitro EMT/emigration explantation assay
The number of cells containing the morpholino (red) or expression construct
(green) that have undergone EMT (i.e. mesenchymal in appearance) and have
emigrated and migrated away from the neural fold explants was determined, using
DAPI, phalloidin and/or vimentin staining, and phase contrast microscopy to
identify individual cells for counting (Shoval et al., 2007; Taneyhill et al., 2007).
This numberwas divided by the total number of cells that had emigrated away from
the explant, and the resulting figure expressed as a percentage. Emigrating cells
were counted in this manner from at least 25 explants over at least two independent
experiments. Phalloidin staining was performed according to the manufacturer's
instructions (Molecular Probes). Explants were also immunostained with an anti-
vimentin antibody (DSHB, clone 40E-C; 1:50) using procedures described above.Results
In ovo knock-down of Cad6B results in premature neural crest
cell emigration
To elucidate the role of Cad6B during neural crest
emigration, we depleted Cad6B protein levels using an
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As controls for specificity, we performed similar experiments
using either the GeneTools standard control MO or a 5 base
pair mismatch Cad6B MO (5 bpmm MO). In all cases, MOs
were introduced into the neural tube by in ovo electroporation
and the efficacy of knock-down was assessed in transverse
sections of embryos immunostained for Cad6B protein. While
Cad6B protein levels are unaffected under both control
conditions (Figs. 1A and B, G and H, respectively), a marked
decrease in immunodetectable Cad6B protein is observed in
embryos treated with Cad6B MO (Figs. 1M and N). To further
assess the specificity of the Cad6B MO, we examined the
protein distribution of other Cadherins in the neural tube or
neural crest, N-cadherin (Ncad) and Cadherin7 (Cad7), in
embryos treated with either control, 5 bpmm or Cad6B MO.
Ncad is normally expressed in apical adherens junctions found
throughout the neuroepithelium (Nakagawa and Takeichi,
1995, 1998), while Cad7 is expressed exclusively on
migrating neural crest cells (Nakagawa and Takeichi, 1995,
1998). We observed no change in the protein distribution of
these other Cadherin family members in the presence of either
type of control MO (Figs. 1C and D, I and J for Ncad; E and
F, K and L for Cad7), or the Cad6B MO (Figs. 1O and P for
Ncad; Q and R for Cad7), demonstrating the specificity of the
Cad6B MO to deplete Cad6B but not other Cadherin proteins
in vivo.Fig. 1. Introduction of Cad6B MO reduces the amount of Cad6B protein in the do
Transverse sections through the trunk of a chick embryo with 21–23 somites at the axi
protein (green) and electroporated with either a lissaminated (red) GeneTools standard
Cad6B (5 bpmm MO), or Cad6B morpholino (Cad6B MO). For each condition, the
embryos analyzed. Upper panels (A–F) show a section analyzed for either Cad6B, Nc
Arrowheads identify cells that are both red and green (yellow) and thus positive for c
panels (G–L) shows a section analyzed for either Cad6B, Ncad, or Cad7 that has bee
cells that are both red and green (yellow) and thus positive for 5 bpmmMO and eithe
analyzed for either Cad6B, Ncad, or Cad7 that has been transfected with the Cad6
reduction in the size of the Cad6B domain in the dorsal neural tube compared to the c
green (yellow) cells present. No changes in Ncad nor Cad7 protein distribution are ob
(yellow) cells that are positive for Cad6B MO and Ncad (P) or Cad7 (R) protein.To address if knock-down of Cad6B alters neural crest
EMT/emigration and subsequent migration, we examined the
effects on the expression of various known markers of
premigratory or migrating neural crest cells. Chick embryos
were electroporated with control or Cad6B MO into the
midbrain region at the 2–4 somite stage (ss), re-incubated, and
then collected at the 8–10 ss, approximately 8 h later.
Experimental embryos were assessed for MO electroporation
efficacy, and only embryos exhibiting signal for MO in the
midbrain region were subjected to further analysis. Embryos
were processed by either whole-mount in situ hybridization for
Sox10, Snail2, FoxD3, or rhoB, or were immunostained with
HNK-1 antibody, to assess potential changes in premigratory or
migratory neural crest populations. In embryos treated with
control MO, no changes were observed in either the pattern of
migratory neural crest cells using the marker Sox10 (n=8), or in
the premigratory neural crest cell domain and the migratory
pathway as assessed by Snail2 (n=9) expression (Figs. 2A–D).
Dynamic temporal changes in neural crest migration, however,
were observed in embryos electroporated with Cad6B MO
(Figs. 2H–K). The amount of Sox10 and Snail2 staining in
neural crest cells as they emigrated away from the dorsal neural
tube throughout the anterior–posterior (A/P) axis of the
midbrain region on the electroporated side was consistently
greater than that observed on the contralateral control side (Figs.
2I and J, arrows). This apparent increase in migration wasrsal neural tube, but does not affect the protein distribution of Ncad or Cad7.
al level +4 and −1 somite. Embryos have been stained for Cad6B, Ncad, or Cad7
control morpholino (Control MO), 5 base pair mismatch control MO specific to
pair of panels shown is a representative section taken from at least 5 different
ad or Cad7 that have been transfected with the control MO (B, D, F, respectively).
ontrol MO and either Cad6B (B), Ncad (D), or Cad7 (F) protein. Middle row of
n transfected with the 5 bpmm MO (H, J, L, respectively). Arrowheads identify
r Cad6B (H), Ncad (J), or Cad7 (L) protein. Lower panels (M–R) show a section
B MO (N, P, R, respectively). Treatment with Cad6B MO results solely in a
ontralateral control side (M, arrow), and, consequently, very few (if any) red and
served upon depletion of Cad6B, as evidenced by the presence of red and green
Fig. 2. Decreased levels of Cad6B result in an increase in neural crest cell migration. Electroporations of either control MO (A–G) or Cad6B MO (H–N) into the
midbrain region of chick embryos at the 2–4 ss; embryos were allowed to develop until the 8–9 ss. Whole-mount in situ hybridizations with antisense ribo-probes for
Sox10 (A and H) or Snail2 (D and K) and indicated sections (B and I and C and J, respectively). Transverse sections of embryos processed by in situ hybridization with
antisense ribo-probes for FoxD3 (E and L) and rhoB (F and M) or by immunohistochemistry for HNK-1 (G and N). Note that panel N is slightly more caudal than
panel G, illustrating the premature migration phenotype observed in embryos treated with Cad6BMO. In all panels, the electroporated side is on the right, as indicated
by the inset or overlaid lissamine (red) fluorescence staining showing cells that have received the MO. Arrows identify an increase in the amount of staining when
compared to the contralateral control side (I and J, and L–N), as well as to control MO-containing embryos (B and C, and E–G). Treatment with control MO had no
effect on neural crest cell migration at any axial level examined.
536 E.G. Coles et al. / Developmental Biology 312 (2007) 533–544observed in 8 out of 11 embryos hybridized with Sox10 and 8 out
of 11 embryos hybridized with Snail2 (representative images;
Figs. 2H–K). A similar increase in staining on the electroporated
side was observed in embryos treated with Cad6B MO when
hybridized for FoxD3 (5 out of 6 embryos) and rhoB (5 out of 7
embryos) (Figs. 2L and M, respectively). Furthermore, HNK-1
immunostaining of Cad6B MO-treated embryos identified more
staining on the electroporated side when compared to the contra-
lateral side and control embryos (4 out of 4 embryos; Fig. 2N).
To quantitate the increase in the number of migratory neural
crest cells following knock-down of Cad6B, every DAPI
positive nuclei that was surrounded by cytoplasmic Sox10 or
Snail2 staining in the migratory streams through 7–10 serial
sections on both the electroporated and non-electroporated side
was counted and recorded in at least 5 embryos (representative
images are shown in Fig. 2). The fold differences were averaged
over the number of sections in which cells were counted, and
the standard error of the mean was calculated and compared for
embryos electroporated with either control MO or Cad6B MO.
We found a statistically significant increase in Sox10-positive
cells (1.32±0.065) and Snail2-positive cells (1.44±0.077) on
the electroporated sides of embryos treated with Cad6B MO
compared to the contralateral, non-electroporated side
(Pb0.00001; unpaired Student's t test), as evidenced by Figs.
2I and J, respectively. In contrast, no change in cell number was
observed with either migratory neural crest cell marker in
embryos treated with control MO (Sox10=1.03±0.020;Snail2=1.03±0.014) (Figs. 2B and C, respectively). Taken
together, our results suggest that depleted levels of Cad6B alter
the timing at which neural crest cells leave the dorsal neural
tube, such that the premature loss of Cad6B upon MO knock-
down leads to early neural crest cell emigration and increased
migration from the dorsal midbrain neural epithelium.
To further examine the effects of depleted levels of Cad6B
on neural crest migration, we analyzed Sox10 expression at both
early and later time points post-electroporation of the Cad6B
MO. As soon as 3 h post-electroporation of the Cad6BMO, we
detected Sox10-positive neural crest cells prematurely migrating
from the midbrain dorsal neural tube (Figs. 3A and B, arrow).
Moreover, as late as 20 h post-electroporation, we also detected
Sox10-expressing neural crest cells prematurely migrating into
the periocular region on the Cad6B MO-transfected side
compared to the control (Figs. 3C–E, arrows). In contrast, no
alterations were noted at 3 and 20 h post-electroporation in
control MO-treated embryos (data not shown).
One potential explanation for the increase in neural crest cell
migration exhibited by embryos treated with Cad6B MO could
be an expansion of the premigratory neural crest cell domain. To
address this possibility, we examined the expression pattern of
the premigratory neural crest cell markers Snail2, FoxD3, and
rhoB in the dorsal neural tube in transverse sections of control
MO- and Cad6BMO-treated embryos (Figs. 2B and C, E and F,
I and J, and L and M, respectively). However, no change in the
size of this region was detected. Other explanations for the
Fig. 3. Introduction of the Cad6BMO results in premature migration of cranial neural crest cells but does not affect cell death or cell proliferation. Electroporations of
Cad6BMO into the chick midbrain region of the embryo at the 2–4 ss followed by either 3 h (A and B), 20 h (C–E), or 8 h (F) of incubation. In panels A–C and F, the
electroporated side is on the right; panels D and E are labeled appropriately. Whole-mount in situ hybridizations with antisense ribo-probes for Sox10 (A and C–E) and
indicated section (B). Black arrows identify Sox10-positive, prematurely migrating neural crest cells as they leave the midbrain (B), and at later developmental stages
migrating into the periocular region (C and E) that is not observed on the contralateral control side (D). (F) Transverse sections of embryos in which a TUNEL assay
has been performed or which have been immunostained for phospho-histone H3 (PH3) after electroporation with either control MO or Cad6BMO do not identify any
changes between MO-treated (red) and control sides. Cells undergoing apoptosis exhibit granular punctate green stain in the TUNEL assay (white arrows) with no
differences observed upon loss of Cad6B. The number of proliferating cells assessed by PH3 staining (green, white arrowheads) also remains unchanged in the
presence or absence of either MO. Individual cells are stained blue with DAPI.
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of cell death and/or cell proliferation upon depletion of normal
Cad6B levels. No apparent changes, however, were observed in
the number of cells undergoing apoptosis (TUNEL and DAPI
stain), cell death (DAPI stain), or cell proliferation (phospho-
histone H3 antibody staining), in Cad6B MO-treated embryos
when compared to control MO-treated embryos (Fig. 3F).
Rather, the premature migration is likely to result from a loss of
epithelial morphology that allows emigration of neural crest
cells from the neural tube.
Knock-down of Cad6B enhances neural crest
emigration/migration in vitro
To further test the hypothesis that Cad6B plays a temporal
role in regulating neural crest emigration, we examined neural
crest cell EMT and emigration using an in vitro assay in which
neural folds are explanted and cultured (Shoval et al., 2007;
Taneyhill et al., 2007). Effects on neural crest cell emigration and
migration were then examined by phase microscopy (data not
shown), DAPI (Figs. 4B, D, F, and H), phalloidin (an actincytoskeleton marker; Figs. 4A and C), and vimentin (an
intermediate filament marker that correlates with mesenchymal
cells; Figs. 4E and G) staining after 2.5 h of culture. This
represents the time at which cells begin to exhibit features
characteristic of emigrating neural crest cells that have just
undergone EMT, such as mesenchymal and fibroblast-like
morphology (Fig. 4, arrows). Based on phalloidin, vimentin, and
DAPI staining, coupled with cell counting, our results show that
fewer cells have undergone EMT, detached from the explant,
emigrated, and become mesenchymal in the presence of control
MO (Figs. 4A and B, E and F; n=32 explants), when compared
to cells containing Cad6BMO (Figs. 4C and D, G and H; n=34
explants). The number of cells undergoing EMT and emigration
when Cad6B protein levels were depleted was significantly
increased over those in control cultures by approximately 3.5-
fold (Pb0.00001; unpaired Student's t test) (Fig. 4I). Taken
together with the in ovo findings, these results indicate that
Cad6B plays a critical role in the initiation and timing of neural
crest emigration in the chick embryo, as down-regulation of
Cad6B is requisite for proper onset of neural crest emigration,
both in vitro and in vivo.
Fig. 4. Knock-down of Cad6B results in an increase in neural crest EMT/emigration in vitro. Explantation and 2.5 h culture of chick dorsal neural folds
(containing the premigratory neural crest) electroporated in vivo with control MO or Cad6B MO (red) and stained for phalloidin (green; A and C), vimentin
(green; E and G), and DAPI (blue; B, D, F, H). Phalloidin staining shows the presence of extended actin-filled processes (arrows), most prominent in emigrating
and migrating neural crest cells from explants taken from embryos electroporated with Cad6B MO compared to control MO (compare A and C). In addition,
emigrating and migrating cells are positive for vimentin, a marker of intermediate filaments and mesenchymal cells (E and G, arrows). Fewer vimentin-positive
(mesenchymal) cells are observed emigrating and/or migrating in explants taken from embryos electroporated with control MO versus Cad6B MO (E and G,
respectively), and this result was confirmed by DAPI staining of the same explants (B and D, F and H). (I) Numerical graph showing standard error of the mean
of explantation results. Cell counting and statistical analysis identify a significant increase in the number of neural crest cells undergoing EMT/emigration in the
presence of Cad6B MO when compared to control MO (Pb0.00001; unpaired Student's t test), such that Cad6B MO treatment results in the production of more
mesenchymal cells.
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crest cell (e)migration
To corroborate our in ovo knock-down data, we examined
the effects of increasing Cad6B levels prior to neural crest EMT
and emigration in the avian embryo. Chick embryos were
electroporated with a control vector (pCIG) or a construct
expressing full-length Cad6B in a bicistronic vector with a
downstream IRES-GFP (pCIG-Cad6B). No change in Cad6B
protein was observed in the presence of pCIG (Figs. 5A–C),
whereas increased Cad6B levels were found throughout the
dorsoventral axis of the neural tube when electroporated with
pCIG-Cad6B, as evidenced by the double positive cells
(yellow) expressing GFP and Cad6B (Figs. 5D–F).
We next addressed whether overexpression of Cad6B alters
neural crest cell emigration and migration in the chick. Embryos
were electroporated with pCIG or pCIG-Cad6B into the
midbrain at the 2–4 ss, re-incubated, and then collected
approximately 8 h later at the 8–10 ss. We then performed
whole-mount in situ hybridization on embryos for Sox10,
Snail2, FoxD3, and rhoB or immunostaining for HNK-1 to
monitor possible changes in neural crest emigration and
migration (Fig. 6). Electroporation of the control vector resulted
in no changes in the timing or number of migrating neural crest
cells by Sox10 (n=11), Snail2 (n=14), FoxD3 (n=6), or rhoB
(n=5) expression or HNK-1 immunostaining (n=4) (Figs. 6A–
G). In contrast, overexpression of Cad6B disrupted neural crest
cell migration, manifested as a reduction in the overall extent of
neural crest cell migration on the electroporated side comparedFig. 5. Introduction of the Cad6B expression construct results in elevated levels of
sections through the trunk of a chick embryo with 21–23 somites at the axial level +4
(pCIG) or a Cad6B expression construct (pCIG-Cad6B) containing an IRES-GFP to
staining for Cad6B protein (red). Upper panels (A–C) show a representative sectio
expression construct. No ectopic Cad6B protein is visible in the neural tube, as eviden
of the dorsal expression domain of Cad6B. Lower panels (D–F) show a representati
Cad6B expression construct. Expression of this construct results in elevated levels of
in the neural tube when compared to the contralateral control side (D, arrows). This
positive for the expression construct and Cad6B protein (F, arrows).to the contralateral control side. This was clearly visible
throughout the A/P axis in transverse sections showing Sox10
(9 out of 11), Snail2 (12 out of 13), FoxD3 (7 out of 8), and
rhoB (4 out of 6) expression and HNK-1 (5 out of 5)
immunostaining (Figs. 6H–N, arrows). Furthermore, neural
crest cells in these embryos tended to stay closely associated
with the neural tube and, those that were able to exit the neural
tube, appeared to cluster (Figs. 6I, J, L, and M; arrow). In some
embryos, overexpression of Cad6B caused a number of cells to
enter the lumen of the neural tube (Figs. 6I, J, and L–N;
arrowheads), an abnormal location and phenotype not observed
in control electroporated embryos. Interestingly, this observa-
tion is similar to one previously seen when Ncad or Cad7 was
ectopically expressed throughout the chick neural epithelium
(Nakagawa and Takeichi, 1998), suggesting that increased
levels of Cadherins generally affect proper neural crest cell
emigration and migration. In addition, in some embryos
overexpressing Cad6B, we observed striking alterations in
neural tube morphology that were not found in embryos
electroporated with the pCIG control construct. In keeping with
the phenotype observed at 8 h, embryos examined 20 h post-
electroporation of pCIG-Cad6B exhibited Sox10-positive cells
adjacent to/associated with the neural tube (Figs. 7A and B), a
phenotype not observed in embryos electroporated with the
control pCIG construct (data not shown).
The apparent decrease in the ability of neural crest cell
migration observed upon overexpression of Cad6B could be
due to an alteration in the size of the premigratory neural crest
domain. To test this possibility, we analyzed Sox10, Snail2,Cad6B protein throughout the dorsoventral axis of the neural tube. Transverse
and −1 somite. Embryos were electroporated with a control expression construct
mark transfected cells (GFP, green) and incubated for 8 h prior to fixation and
n from at least 4 different embryos that have been transfected with the control
ced by the absence of any new cells that are both red and green (yellow) outside
ve section from at least 4 different embryos that have been transfected with the
Cad6B protein as well as an increase in the ventral distribution of Cad6B protein
results in the presence of multiple red and green (yellow) cells that are double-
Fig. 6. Elevated levels of Cad6B protein disrupt the migration of neural crest cells. Electroporations of either pCIG (A–G) or pCIG-Cad6B (H–N) into the midbrain
region of chick embryos at the 2–4 ss; embryos were allowed to develop until the 8–9 ss. Whole-mount in situ hybridization with antisense ribo-probes for Sox10 (A
and H) or Snail2 (D and K) and indicated sections ((B and I) and (C and J), respectively). Transverse sections of embryos processed by in situ hybridization for FoxD3
(E and L) and rhoB (F and M), or immunohistochemistry with HNK-1 (G and N). In all panels, the electroporated side is on the right, as indicated by the inset GFP
image (green fluorescence) showing cells that have received the transfected DNA construct. Arrows identify migratory neural crest cells that have failed to properly
migrate away and thus aggregate adjacent to the dorsal neural tube, when compared to the contralateral control side (I and J, and L–N), as well as to pCIG
electroporated control embryos (B and C and E–G). Arrowheads identify cells that have entered into the lumen of the neural tube (I and J, and L–N).
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markers in sections through electroporated embryos (Figs. 6I,
J, L, and M). No changes, however, were noted in the size of
the premigratory neural crest domain, as determined by
counting the number of Snail2-positive cells in the dorsal
neural tube region (treated and contralateral control side) of
embryos electroporated with either pCIG or pCIG-Cad6B. In
addition, elevated levels of Cad6B did not affect apoptosis
(TUNEL and DAPI), cell death (DAPI), or cell proliferation
(phospho-histone H3) in treated embryos (Fig. 7C). Interest-
ingly, however, cells present in the lumen of the neural tube of
embryos electroporated with the Cad6B expression construct
were TUNEL positive, suggesting they were apoptotic (Fig.
7C, arrows). Collectively, our data suggest that elevated levels
of Cad6B lead to a decrease in the ability of neural crest cells
to emigrate, and subsequently migrate away, from the dorsal
neural tube.
We also assessed the effects of elevated Cad6B on
emigration in vitro by explanting and culturing neural folds
electroporated and expressing pCIG or pCIG-Cad6B. However,
under in vitro conditions, we observed no effects on neural crest
emigration and migration when assessing cell morphology
through phase microscopy and staining for phalloidin (Figs. 8A
and C), DAPI (Figs. 8B, D, F, and H), and vimentin (Figs. 8E
and G). At 2.5 h, control and experimental cultures were
indistinguishable from each other in the absence (Figs. 8A and
B, E and F; n=25) or presence (Figs. 8C and D, G and H;n=25) of elevated Cad6B protein, with no statistical significant
differences (Fig. 8I).
Discussion
Cadherins, in conjunction with members of the catenin
family of intracellular proteins, are the main components of
cellular adherens junctions (Pla et al., 2001; Wheelock and
Johnson, 2003; Lien et al., 2006). Localized to the apical
surface of the cell, these junctions contribute to overall
epithelial polarity by assisting in the formation of cortical
actin cables surrounding the cell. Besides serving a fundamental
role in mediating calcium-dependent cell–cell adhesion,
Cadherins also function to modulate different intracellular
signaling processes by integrating signals from the extracellular
matrix to cytoplasmic components of the cell. For example,
cleavage of the cytoplasmic tail of Ncad releases a C-terminal
product that functions in downstream transcriptional events,
ultimately resulting in BMP-mediated neural crest delamination
in avian embryos (Shoval et al., 2007). In addition, the
cytoplasmic domain of E-cad has been shown to be a regulator
of mammary epithelial morphogenesis (Delmas et al., 1999).
Various Cadherins are expressed during the formation of the
neural crest and its derivatives. In avian embryos, there are
initially high levels of Cad6B and Ncad in neural crest precursor
cells located in the dorsal neural tube (Duband et al., 1988;
Akitaya and Bronner-Fraser, 1992; Nakagawa and Takeichi,
Fig. 7. Neural crest cells expressing elevated levels of Cad6B remain associated
with the neural tube with no change in cell proliferation nor apoptosis in the
neural tube. Electroporations of the pCIG-Cad6B expression construct (green)
into the chick midbrain region of the embryo at the 2–4 ss followed by either
20 h (A and B) or 8 h (C) of incubation. In all panels, the electroporated side is
on the right. Whole-mount in situ hybridization for Sox10 (A), and indicated
section (B), identifies a number of Sox10-positive cells adjacent to the neural
tube (arrows), a phenotype not detected in control embryos. (C) Transverse
sections of embryos in which a TUNEL assay has been performed or which have
been immunostained for phospho-histone H3 (PH3) (both red) after electro-
poration with either pCIG or pCIG-Cad6B do not identify any changes between
transfected (GFP, green) and control sides in the neural epithelium. Cells present
in the lumen of the neural tube of embryos overexpressing Cad6B are
undergoing apoptosis and exhibit granular punctate red stain (white arrows). The
number of proliferating cells assessed by phospho-histone H3 staining (red,
white arrowheads) remains unchanged in the presence or absence of elevated
levels of Cad6B. Individual cells are stained blue with DAPI.
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neural ectoderm, with much lower levels found in the neural
plate (Hatta and Takeichi, 1986). Prior to EMT and neural crest
emigration, Ncad, and then slightly later Cad6B, are both down-
regulated in the dorsal neural tube (Nakagawa and Takeichi,
1995; Liu and Jessell, 1998; Sela-Donenfeld and Kalcheim,
1999; Pla et al., 2001; Shoval et al., 2007; Taneyhill et al.,
2007), with a concomitant increase in Cad7 and Cadherin11
expression on migrating crest cells, presumably to facilitate
transient cell–cell interactions as neural crest cells migrate away
from the neural tube to their final destinations in the embryo
(Nakagawa and Takeichi, 1995, 1998; Kulesa and Fraser, 2000;
Borchers et al., 2001). Upon homing and differentiation, neuralcrest cells subsequently express other Cadherins depending
upon the embryonic derivative they are fated to become. For
instance, melanocytes found in the dermis, basement mem-
branes, and hair bulb express E-cad, while Ncad becomes up-
regulated in aggregating neural crest cells prior to the formation
of both the dorsal root and sympathetic ganglia (Pla et al.,
2001), and during the patterning of the neural crest-derived
cardiac outflow tract in the mouse (Luo et al., 2006).
Previous studies have investigated the role of some of the
Cadherins expressed during neural crest emigration. Inactiva-
tion of Ncad or the use of calcium ion chelators in the chick
results in premature neural crest emigration (Newgreen and
Gooday, 1985; Akitaya and Bronner-Fraser, 1992; Bronner-
Fraser et al., 1992; Pla et al., 2001), whereas overexpression of
Ncad or Cad7 in the chick dorsal neural tube suppresses neural
crest EMT and migration, particularly along the dorsolateral
pathway (Nakagawa and Takeichi, 1998). We have recently
identified a direct regulatory relationship between another
Cadherin, Cad6B, and Snail2, a transcriptional repressor
expressed in the premigratory neural crest cell population
(Taneyhill et al., 2007). This regulatory relationship, coupled
with the temporal and spatial expression pattern of Cad6B,
suggested that Cad6B might play an important role during
neural crest EMT and emigration. To directly assess the role of
Cad6B during neural crest EMT and emigration, we used a
combined loss-of-function and gain-of-function approach. MO-
mediated protein knock-down demonstrates that Cad6B plays
an important temporal role in regulating neural crest emigration,
such that its loss leads to precocious neural crest EMT and
earlier emigration of neural crest cells away from the dorsal
neural tube. This effect is specific to depletion of Cad6B, as we
observe no change in the protein distribution of other
Cadherins, such as Ncad and Cad7, in Cad6B MO-treated
embryos. In ovo, we observe a statistically significant 1.4-fold
increase in the number of migrating neural crest cells in
embryos with depleted levels of Cad6B. This is all the more
remarkable in light of the intrinsic mosaic nature of MO
transfections in the embryo, in that not all cells actually receive
the MO and consequently reduce Cad6B protein levels.
Furthermore, this premature emigration can be observed at
multiple time points after introduction of Cad6B MO into the
embryo, manifested as an increase in the number of migratory
crest cells in the periphery of the embryo. The precocious
migration is not due to changes in the rates of cell proliferation
or cell death of the premigratory or migratory neural crest cell
population, nor to changes in the timing of neural crest
induction, but rather is due to an effect on the timing of neural
crest cell delamination from the dorsal neural tube.
These in vivo findings were corroborated by examining
effects on neural crest emigration using an explantation assay in
which neural folds were electroporated with either control or
Cad6B MO and cultured in vitro. This in vitro assay, coupled
with staining for appropriate molecular markers, allows one to
accurately assess the mesenchymal morphology of individual
cells that have just undergone EMT and are emigrating and
migrating. Under these conditions, knock-down of Cad6B
results in a statistically significantly 3.5-fold increase in neural
Fig. 8. Overexpression of Cad6B does not alter neural crest emigration and migration in vitro. Explantation and 2.5 h culture of chick dorsal neural folds (containing
the premigratory neural crest) electroporated in vivo with either pCIG or pCIG-Cad6B (green) and stained for phalloidin (red; A and C), vimentin (red; E and G), and
DAPI (blue; B, D, F, H). Phalloidin staining shows the presence of extended actin-filled processes in emigrating and migrating neural crest cells from explants taken
from embryos electroporated with pCIG or pCIG-Cad6B (A and C, arrows). In addition, emigrating and migrating cells in both cultures are positive for vimentin, a
marker of intermediate filaments and mesenchymal cells (E and G, arrows). (I) Numerical graph showing standard error of the mean of explantation results. Statistical
analysis does not identify any significant difference between the number of neural crest cells emigrating/migrating in neural fold explant cultures taken from embryos
electroporated with pCIG (48.0%) or pCIG-Cad6B (48.2%).
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cells. This knock-down phenotype is quite striking, as
alterations in the level of just one molecule involved in cell–
cell adhesion and EMT led to significant changes in the
numbers of emigrating neural crest cells in vitro. This finding
further underscores the critical regulatory relationship betweenSnail2 and Cad6B during neural crest emigration: down-
regulation of Cad6B must occur for neural crest cells to exit the
neural tube, and this is achieved, in part, by Snail2 repression.
Our current study suggests that the repression of Cad6B
requires tight temporal control, as premature down-regulation of
Cad6B leads to the earlier onset of neural crest emigration.
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associated with Cad6B repression must be regulated in the
proper spatiotemporal manner in order to ensure subsequent
neural crest cell migration in the avian embryo.
Further substantiating the Cad6B knock-down phenotype,
overexpression of Cad6B in vivo results in decreased or
disrupted neural crest cell emigration and migration. This effect
is observed at varying time points post-electroporation, as we
consistently observe cells aggregating by the dorsal neural tube
and find a decrease in the total number of neural crest cells
migrating into the periphery. Furthermore, overexpression of
Cad6B does not alter cell proliferation or cell death rates in
either the neural tube or migratory neural crest cells, and neural
crest induction appears unaffected in these embryos. Cad6B
expression is normally restricted to the dorsal neural tube, a site
that correlates with that of the premigratory neural crest. As
such, the forced expression of Cad6B in more ventral and thus
ectopic regions sometimes affects the architecture of the neural
tube as well, as observed in some of our electroporation
experiments, perhaps via alterations in the shape and/or
organization of the neural epithelial cells. Having high levels
of Cad6B in the premigratory neural crest, however, creates a
potentially problematic situation, as neural crest cells under-
going EMT/emigration must down-regulate Cad6B to facilitate
proper migration, and these precursor cells may be unable to
effectively do so in the presence of continuous Cad6B
expression. Furthermore, we often observed cells in the lumen
of the neural tube, a phenotype reminiscent of that seen when
Ncad or Cad7 is overexpressed (Nakagawa and Takeichi, 1998).
Similar to the conclusions reached by this previous study, here it
is likely that cells enter the lumen as a result of (1) Cad6B
localization throughout the apical and lateral surfaces of the
neuroepithelium, with the loss of restricted Cad6B protein
distribution dorsally, and/or (2) the loss of potential direction-
ality in neural crest cell emigration as cells attempt to exit the
neural tube. It should be noted that the penetrance of this
phenotype is likely due to the mosaic nature of the electropora-
tion technique.
To investigate the mechanism by which Cad6B controls
neural crest cell emigration and subsequent migration, we
performed in vitro explantation assays with neural folds
overexpressing Cad6B. These results reveal that premigratory
neural crest cells in the dorsal neural tube are capable of
emigrating from the explants, even in the presence of ectopic
Cad6B, implying that Cad6B does not have a global effect on
cell motility. The discrepancy observed in our in vivo (where
cells fail to migrate properly) and in vitro (where cells migrate
normally) Cad6B overexpression assays is likely due to the
differences between the more complex/non-permissive extra-
cellular matrix in the embryo and the uniform/permissive
substrate of the in vitro culture dish. Thus, our data support a
hypothesis in which changes in cell–cell adhesion are
precluding normal neural crest cell migration in embryos
overexpressing Cad6B, and that loss of Cad6B-mediated
adhesion is critical to permit timely emigration of neural crest
cells from the dorsal neural tube in the embryo. As such, this
apparent increase in cell–cell adhesion among those emigratingneural crest cells overexpressing Cad6B in the embryo proper
can sometimes result in a ‘traffic jam’ with cells ‘backing up’
and sometimes spilling into the lumen of the neural tube.
Inevitably, these cells undergo apoptosis because of their
improper location in the embryo. It is also possible that those
neural crest cells that emigrate and exit the neural tube (with or
without altered levels of Cad6B) may subsequently adhere and
become ‘trapped’ by those cells situated proximal to the neural
tube, thus precluding further migration.
Our results show that the controlled temporal and spatial
expression of Cadherins in the neural tube prior to and during
neural crest cell migration appears to be important, at least in
part, for proper neural crest development. Ncad is broadly
expressed throughout the neural epithelium prior to the onset of
neural crest emigration, and it is down-regulated in the dorsal
premigratory neural crest cell region just prior to emigration in a
BMP-mediated fashion (Nakagawa and Takeichi, 1995; Shoval
et al., 2007). Concurrently, Cad6B is up-regulated in the
premigratory region, perhaps initially to distinguish the
presumptive dorsal premigratory/progenitor neural crest cell
region from the surrounding neural epithelial cells (Liu and
Jessell, 1998; Sela-Donenfeld and Kalcheim, 1999). The
localization of Cad6B to the premigratory neural crest region
and its subsequent down-regulation appear to be requisite for
controlling the precise timing of emigration and the onset of
proper neural crest cell migration in a Snail2-dependent manner
(Taneyhill et al., 2007; this study). Taken together, our results
reveal a previously unappreciated role for Cad6B in regulating
the timing of neural crest emigration and the exit of neural crest
cells from the dorsal neural tube in the cranial region of the
avian embryo.
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